Original language | English (US) |
---|---|
Pages (from-to) | e193-e194 |
Journal | Diabetes care |
Volume | 39 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2016 |
Bibliographical note
Funding Information:This work was funded by a grant from the Leona M. and Harry B. Helmsley Charitable Trust; by the National Center for Research Resourcesand theNationalCenter forAdvancing Translational Sciences, National Institutes of Health, throughgrantsUL1TR000003 (University of Pennsylvania), UL1TR000064 (University of Florida), and UL1TR001108 (Indiana University); and by Locemia Solutions ULC. Studies at the Barbara Davis Center for Childhood Diabetes were performed in their infusion center and not the hospital Clinical Translational Research Center. Locemia Solutions provided the intranasal glucagon product.